106
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease

, , , , &
Pages 639-646 | Published online: 06 Sep 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Előd Ernő Nagy, Attila Rácz, Edit Urbán, Gabriella Terhes, Timea Berki, Emőke Horváth, Anca M Georgescu & Iringó E Zaharia-Kézdi. (2016) Diagnostic pitfalls in a young Romanian ranger with an acute psychotic episode. Neuropsychiatric Disease and Treatment 12, pages 961-967.
Read now

Articles from other publishers (16)

Muhammad Naeem, Derek Enos, Shazia Shah, Nidhi Patel & Tara Fisher. (2021) Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone. Cureus.
Crossref
Lorraine Johnson, Mira Shapiro, Raphael B. Stricker, Joshua Vendrow, Jamie Haddock & Deanna Needell. (2020) Antibiotic Treatment Response in Chronic Lyme Disease: Why Do Some Patients Improve While Others Do Not?. Healthcare 8:4, pages 383.
Crossref
Robert Bransfield. (2018) Neuropsychiatric Lyme Borreliosis: An Overview with a Focus on a Specialty Psychiatrist’s Clinical Practice. Healthcare 6:3, pages 104.
Crossref
Kellie J Goodlet & Kathleen A Fairman. (2018) Adverse Events Associated With Antibiotics and Intravenous Therapies for Post–Lyme Disease Syndrome in a Commercially Insured Sample. Clinical Infectious Diseases.
Crossref
Marianne Middelveen, Eva Sapi, Jennie Burke, Katherine Filush, Agustin Franco, Melissa Fesler & Raphael Stricker. (2018) Persistent Borrelia Infection in Patients with Ongoing Symptoms of Lyme Disease. Healthcare 6:2, pages 33.
Crossref
Marcus Davidsson. (2018) The Financial Implications of a Well-Hidden and Ignored Chronic Lyme Disease Pandemic. Healthcare 6:1, pages 16.
Crossref
Anneleen Berende, Hadewych J.M. ter Hofstede, Fidel J. Vos, Henriët van Middendorp, Michiel L. Vogelaar, Mirjam Tromp, Frank H. van den Hoogen, A. Rogier T. Donders, Andrea W.M. Evers & Bart Jan Kullberg. (2016) Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease. New England Journal of Medicine 374:13, pages 1209-1220.
Crossref
Uwe Koedel, Volker Fingerle & Hans-Walter Pfister. (2015) Lyme neuroborreliosis—epidemiology, diagnosis and management. Nature Reviews Neurology 11:8, pages 446-456.
Crossref
Raphael B. Stricker & Lorraine Johnson. (2014) Lyme Disease: Call for a “Manhattan Project” to Combat the Epidemic. PLoS Pathogens 10:1, pages e1003796.
Crossref
Mark S. Klempner, Phillip J. Baker, Eugene D. Shapiro, Adriana Marques, Raymond J. Dattwyler, John J. Halperin & Gary P. Wormser. (2013) Treatment Trials for Post-Lyme Disease Symptoms Revisited. The American Journal of Medicine 126:8, pages 665-669.
Crossref
B. White, R. A. Seaton & T. J. Evans. (2012) Letter of response to Stricker et al.. QJM 106:2, pages 202-203.
Crossref
R. B. Stricker, A. K. DeLong & L. Johnson. (2012) Outpatient parenteral antibiotic therapy for Lyme borreliosis: a 'real world' view. QJM 106:2, pages 201-203.
Crossref
Raphael B StrickerLorraine Johnson. (2012) Spirochetal ‘debris’ versus persistent infection in chronic Lyme disease: from semantics to science. Future Microbiology 7:11, pages 1243-1246.
Crossref
Allison K. DeLong, Barbara Blossom, Elizabeth L. Maloney & Steven E. Phillips. (2012) Antibiotic retreatment of Lyme disease in patients with persistent symptoms: A biostatistical review of randomized, placebo-controlled, clinical trials. Contemporary Clinical Trials 33:6, pages 1132-1142.
Crossref
BRITTANY SAMBRANO, RACHEL GORDON, RANA MAYS, WHITNEY LAPOLLA & NOAH SCHEINFELD. (2012) Intravenous antibiotics used in dermatology. Dermatologic Therapy 25:1, pages 70-81.
Crossref
Raphael B. Stricker & Lorraine Johnson. (2011) The Pain of Chronic Lyme Disease: Moving the Discourse Backward?. The FASEB Journal 25:12, pages 4085-4087.
Crossref